SAN FRANCISCO, May 15, 2023 /PRNewswire/ — Invitae (NYSE: NVTA), a leading medical genetics company, today announced that it intends to appeal the verdict delivered by a jury at the United States District Court for the District of Delaware. The jury found that Invitae’s products using Anchored…
Source: www.marketscreener.com – Read more
Indonesia’s digital health maturity in 2023 revealed and more briefs
The Indonesian Ministry of Health has announced the results of a recent digital maturity assessment for health services, revealing an average score of 2.73 out